Navigation Links
Medical science helps UK athletes reach peak performance
Date:12/9/2010

A new hand-held medical device will help UK athletes reach the top of their game when preparing for upcoming sporting competitions. UK Sport, the UK's high performance sports agency, has reached an agreement to become the first organisation to use cutting edge technology developed by Argento Diagnostics to improve training programmes for athletes.

Elite athletes will be able to monitor various proteins which reveal details about the condition of the body known as biomarkers before, during and after training sessions. These biomarkers can give a clear indication of their physical health and the effectiveness of a particular training programme. Everyone reacts differently to training, so understanding how activities affect the body helps ensure that athletes follow the best programmes for them and avoid injury. This is particularly important for elite level athletes, where small changes in fitness can mean the difference between success and failure.

These biomarker tests are currently carried out at centralised laboratories. However the time taken to send samples to the laboratory and receive the results can limit the benefits.

Argento Diagnostics a spin out of the National Physical Laboratory, the UK's National Measurement Institute has developed a rapid diagnostic technology to solve this and other problems associated with slow clinical laboratory diagnosis. Argento's hand-held device provides a quick, full diagnosis from a single small sample (such as blood, urine or saliva), returning results within minutes. As well as providing real time data for training, the results can also quickly identify injuries or medical conditions, enabling rapid treatment before long-term damage can be done, and therefore increase chance of a quick recovery.

Argento's portable device uses nanotechnology to analyse the sample. The sample is mixed with silver nanoparticles coated with a binding unit, an antibody, against a specific biological
'/>"/>

Contact: David Lewis
david@proofcommunication.com
084-568-01865
National Physical Laboratory
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Rush-Copley Medical Center Selects Pharmacy Xpert from Thomson Reuters to Improve Medication Management
2. Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely
3. Integrated Medical Systems Technology Recognized as Qualified Therapeutic Discovery
4. Wound Management Technologies to Present at LifeTech Capital Miami Medical Investors Conference
5. Cardium to Present at the LifeTech Capital Miami Medical Investors Conference
6. R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany
7. Reportlinker Adds Next Generation U.S. and E.U. Biomaterials/BioMedical Devices: Market Trends & Commercial Implications
8. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11
9. CSA Medical Selected to Present at Mid-Atlantic Bio Conference
10. ZONARE Medical Systems Ranked Among Fastest Growing Companies By Silicon Valley Business Journal
11. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), ... oncology, today announced positive updated results from its ... the treatment of unresectable glioblastoma multiforme (GBM), a ... trial is designed to investigate the preliminary efficacy ... have progressed following prior treatment with surgery, radiation ...
(Date:5/21/2015)... Tunnell Consulting, Inc. today ... senior statistician and Principal, a position to which she ... management and analysis of complex and large data sets ... “We’re delighted to have Julia join the Tunnell team ... Dr. Philippe Cini, Group Vice President and leader of ...
(Date:5/20/2015)... 20, 2015  Select Medical Corporation ("Select") (NYSE: ... Commission granted early termination of the waiting period ... 1976, as amended, applicable to the acquisition of ... joint venture that Select has created with Welsh, ... previously announced, MJ Acquisition Corporation has signed a ...
(Date:5/20/2015)... Mass. , May 20, 2015  Haemonetics Corporation ... Concannon , President & CEO, will present at The ... York on June 1 st , 2015 ... may access Mr. Concannon,s presentation live via webcast at: ... Haemonetics (NYSE: HAE ) is a global ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... is to make a major contribution to our fuel supplies, ... insect helpers, says Michael Scharf, an assistant professor of entomology ... review to be published in Biofuels, Bioproducts & Biorefining ... enzymes produced by both termites and the micro-organisms that inhabit ...
... Oct. 21 Boston Scientific,Corporation (NYSE: BSX ) today ... as well as guidance for net sales and,earnings per share ... quarter highlights: -- Reported net sales of $1.978 billion ... stent (DES) market leadership -- Achieved worldwide cardiac rhythm ...
... to Pay Amylin $125 Million and Extend $165 Million Line of Credit to ... ... 21 Amylin,Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly and Company ... for,exenatide once weekly, a development compound that, if approved, would,become the first once ...
Cached Biology Technology:Digesting the termite digestome -- a way to make biofuels? 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 4Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 5Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 6Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 7Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 8Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 9Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 10Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 11Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 12Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 13Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 14Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 15Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 16Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 17Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 18Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 19Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 20Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 21Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 22Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 23Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 24Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 25Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 26Boston Scientific Announces Results for Third Quarter Ended September 30, 2008 27Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly 2Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly 3
(Date:4/13/2015)... According to a recently ... & Opportunities, 2020", the global biometrics market is ... till 2020. The biometrics market is garnering attention ... review of biometric management systems. The constant development ... greater efficiency, are resulting in increasing installation of ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
Breaking Biology News(10 mins):Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... NEW YORK and LEON, GUANAJUATO MEXICO, Aug. 18 ... control and identity management market, announced today that it ... in Leon, Guanajuato, Mexico. Portoss, a Leon-based company, specializes ... This latest partnership between Portoss and the City of ...
... AMES - A special set of sugars found ... body,s natural defenses as well as vaccines, say two ... a first step in understanding a disease family that ... vaccines or cures. Nicola Pohl, professor of chemistry, ...
... In findings that push back the clock on the ... Earth, Princeton scientists may have discovered the oldest fossils ... living in ocean reefs about 650 million years ago. ... deposit in South Australia, represent the earliest evidence of ...
Cached Biology News:Global Rainmakers Delivers World Class Iris Capability for Portoss 2Global Rainmakers Delivers World Class Iris Capability for Portoss 3ISU researchers discover cause of immune system avoidance of certain pathogens 2ISU researchers discover cause of immune system avoidance of certain pathogens 3Possible discovery of earliest animal life pushes back fossil record 2Possible discovery of earliest animal life pushes back fossil record 3Possible discovery of earliest animal life pushes back fossil record 4
... Monoclonal to L1 Cell Adhesion Molecule ... located in Xq28, is involved in three ... aqueduct of Sylvius); 2) MASA (mental retardation, ... SPG1 (spastic paraplegia). Immunogen: ...
...
Immunogen: C terminus [VQLKRSKNDSKPYC] of cardiac elav-type RNA-binding protein (ETR-3) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human ABCG2 MAb (Clone 5D3)...
Biology Products: